Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0RM8Z | ISIN: US1887691038 | Ticker-Symbol: UR9A
Siehe auch CLINUVEL PHARMACEUTICALS LIMITED
Frankfurt
06.06.25 | 08:07
5,550 Euro
-1,77 % -0,100
Branche
Biotechnologie
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
CLINUVEL PHARMACEUTICALS LIMITED ADR Chart 1 Jahr
5-Tage-Chart
CLINUVEL PHARMACEUTICALS LIMITED ADR 5-Tage-Chart

Aktuelle News zur CLINUVEL PHARMACEUTICALS LIMITED ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCLINUVEL PHARMACEUTICALS LIMITED: SCENESSE in Vitiligo - A Global Update52
26.05.Clinuvel: "Weglegeaktie", die drei Generationen begeistern wird?71
21.05.CLINUVEL PHARMACEUTICALS LIMITED: SCENESSE EPP data featured at EADV Symposium31
08.05.CLINUVEL PHARMACEUTICALS LIMITED: Ceasing to be a substantial holder28
07.05.Clinuvel Pharmaceuticals Limited: CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105528Executive summary Recruitment target of 200 vitiligo patients (Fitzpatrick skin type III-VI) in CUV105 study achievedRandomised trial, 20-week treatment protocol plus 6-month follow upStudy sites...
► Artikel lesen
07.05.Clinuvel Pharmaceuticals reaches patient recruitment milestone ahead of Phase III Scenesse vitiligo trial17
06.05.CLINUVEL PHARMACEUTICALS LIMITED: CUV recruits 200 patients in Phase III vitiligo trial CUV1053
CLINUVEL PHARMACEUTICALS LIMITED ADR Aktie jetzt für 0€ handeln
23.04.CLINUVEL PHARMACEUTICALS LIMITED: Notification regarding unquoted securities - CUV33
08.04.CLINUVEL PHARMACEUTICALS LIMITED: Notification of cessation of securities - CUV19
06.04.CLINUVEL PHARMACEUTICALS LIMITED: Section 708A Cleansing Statement12
06.04.CLINUVEL PHARMACEUTICALS LIMITED: Application for quotation of securities - CUV8
06.04.CLINUVEL PHARMACEUTICALS LIMITED: Application for quotation of securities - CUV4
01.04.Biocurious: While other biotechs scratch around for cash, Clinuvel is accused of having too much23
01.04.CLINUVEL PHARMACEUTICALS LIMITED: Change in substantial holding20
26.03.Clinuvel reports positive early results for stroke treatment study68
26.03.Clinuvel stroke drug shows 'positive' results - but some adverse effects left unclear32
26.03.Why Clinuvel, Orthocell, Vulcan, and Wildcat shares are storming higher20
25.03.CLINUVEL PHARMACEUTICALS LIMITED: Notification of buy-back - CUV2
25.03.CLINUVEL PHARMACEUTICALS LIMITED: CLINUVEL renews share buy-back program5
25.03.CLINUVEL PHARMACEUTICALS LIMITED: Update - Notification of buy-back - CUV-
Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1